Virtual Medicinal Product (VMP) - Naproxen 125mg/5ml oral suspension
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Naproxen 125mg/5ml oral suspension | Start Date 18-06-2003 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Non-availability Indicator
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- M01AE02
- BNF Codes
-
- BNF code 10010100
| Code | Start Date | End Date |
|---|---|---|
| 42107311000001109 | 28-07-2023 | |
| 329852000 | 18-06-2003 | 27-07-2023 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Naproxen | Based on Ingredient Substance | 25 mg | 1 ml |
Name
Naproxen
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
25
Strength and UOM (Dmr)
1
Parent Products
-
VTMNaproxen
-
VMP(Current) Naproxen 125mg/5ml oral suspension
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 ml | ||
| 100 ml | ||
| 240 ml |